Core Viewpoint - Elixxer Ltd. successfully held its annual and special meeting of shareholders on December 30, 2025, where all proposed resolutions were approved by an overwhelming majority of votes cast. Group 1: Shareholder Meeting Results - A total of 3,798,208 shares were voted at the meeting, representing 33.50% of the total issued and outstanding common shares of the company [2] - All matters submitted for approval were passed with significant support from shareholders [2] Group 2: Director Elections - The following individuals were elected as directors of the company until the next annual meeting: - Jayahari Balasubramaniam: 3,759,707 votes in favor (98.99%) [3] - Alexey (Alex) Kanayev: 3,759,737 votes in favor (98.99%) [3] - Mark E. Romano: 3,759,737 votes in favor (98.99%) [3] - Edward Milewski: 3,759,737 votes in favor (98.99%) [3] Group 3: Auditor Appointment - CAN Partners LLP was appointed as the company's auditors for the upcoming year with 99.06% of votes in favor [3] Group 4: Special Resolutions - A special resolution to amend the articles of incorporation for a name change was approved with 3,760,311 votes in favor (99.00%) [4] - A special resolution for the consolidation of shares on a basis of up to 90 pre-consolidation shares for 1 post-consolidation share was approved with 3,754,823 votes in favor (98.86%) [4] - The stock option plan was re-approved with 3,756,098 votes in favor (98.99%) [5] - A resolution to issue common shares to settle indebtedness was approved with 123,627 votes in favor (75.01%) [5] Group 5: Delisting Resolution - A resolution for voluntary delisting from TSXV was passed with 113,932 votes in favor (69.13%) [6] Group 6: Company Overview - Elixxer Ltd. is a Canadian public company listed on the TSX Venture Exchange and the US OTC-Pink exchange, focusing on investments in Canada and other countries, and seeking new high-growth opportunities [7]

Core Points - LevelJump Healthcare Corp. has called an annual and special meeting of shareholders to be held on May 26, 2026, in response to a requisition from certain shareholders seeking to remove all current directors and appoint five new directors [1][2]. Group 1: Meeting Details - The Board decided to hold a single shareholder meeting to address both annual business and the requisition matters, which is the earliest date for audited financial statements to be available for consideration [2]. - This approach is seen as a prudent use of shareholder capital, avoiding the costs associated with holding separate meetings in close proximity [2]. - Shareholders will receive further details about the meeting and voting procedures in a management information circular prior to the meeting [3]. Group 2: Company Overview - LevelJump Healthcare Corp. provides telehealth solutions through its Teleradiology division and in-person radiology services via its Diagnostic Centres, focusing on critical care for urgent and emergency patients [5].

Core Points - The Company will hold its annual general meeting on June 20, 2025, at 10:00 AM Estonian time [1] - The agenda includes the approval of the annual report for the financial year 2024, which shows a balance sheet value of €1,873,680 and a net profit of €167,409 [2] - The net profit for 2024 is proposed to be carried to accumulated profit [2] - AS PricewaterhouseCoopers is proposed to be appointed as the auditor for the financial year 2025 [3] - A one-off payment of €2,400 and a monthly fee of €200 will be paid to Supervisory Board member Aivar Kempi starting from June 21, 2025 [3] Meeting Participation - Shareholders entitled to participate will be determined as of June 13, 2025 [4] - Registration for the meeting starts at 09:00 AM on the meeting day [4] - Individual shareholders must present an identity document, while corporate shareholders must provide additional documentation [5] Proxy and Voting - Shareholders can notify the Company of the appointment or revocation of a representative via email or in person by June 19, 2025 [6] - A template for power of attorney is available on the Company's website [7] - Shareholders holding at least 1/20 of the share capital can demand additional agenda items if requested by June 5, 2025 [8] Draft Resolutions - Shareholders can submit draft resolutions for agenda items by June 17, 2025 [9] - The Management Board is obligated to provide information on the Company's activities unless it may cause significant damage to the Company [10] Documentation - Documents related to the general meeting, including the annual report and auditor's report, will be available for examination on the Company's website and at its office [11] - As of May 30, 2025, the Company's share capital is divided into 4,499,061 shares, each granting one vote [12]